Supplemental material
Open access
2,820
Views
4
CrossRef citations to date
0
Altmetric
Research Papers
From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19?
Matteo PavanMolecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy
, Davide BassaniMolecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy
, Mattia SturleseMolecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italyhttps://orcid.org/0000-0003-3944-0313
& Stefano MoroMolecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, ItalyCorrespondence[email protected]
https://orcid.org/0000-0002-7514-3802
https://orcid.org/0000-0002-7514-3802
Pages 1704-1714
|
Received 17 Apr 2022, Accepted 20 May 2022, Published online: 13 Jun 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.